Zimmer Biomet Holdings Investing Cash Flow increased by 50.6% to -$159.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 50.0%, from -$106.00M to -$159.00M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 40.7% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$109.90M | -$125.20M | -$146.20M | -$81.10M | -$243.20M | -$85.20M | -$112.50M | -$149.40M | -$243.10M | -$165.60M | -$220.80M | -$195.00M | -$247.00M | -$154.90M | -$291.20M | -$106.00M | -$1.38B | -$163.30M | -$322.00M | -$159.00M |
| QoQ Change | — | -13.9% | -16.8% | +44.5% | -199.9% | +65.0% | -32.0% | -32.8% | -62.7% | +31.9% | -33.3% | +11.7% | -26.7% | +37.3% | -88.0% | +63.6% | <-999% | +88.2% | -97.2% | +50.6% |
| YoY Change | — | — | — | — | -121.3% | +31.9% | +23.1% | -84.2% | +0.0% | -94.4% | -96.3% | -30.5% | -1.6% | +6.5% | -31.9% | +45.6% | -460.5% | -5.4% | -10.6% | -50.0% |